Related Experiment Video
Updated: Feb 2, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
A Practical Score for Prediction of Outcome After Cerebral Venous Thrombosis
Miguel A Barboza1,2, Erwin Chiquete3, Antonio Arauz1
1Stroke Clinic, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Insights
A new Cerebral Venous Thrombosis Grading Scale (CVT-GS) helps predict short-term outcomes. This tool identifies high-risk patients, improving clinical decision-making and patient stratification for trials.
Area of Science:
- Neurology
- Clinical Medicine
- Medical Research
Background:
- Cerebral Venous Thrombosis (CVT) patients often survive short-term, but predicting unfavorable outcomes remains challenging.
- Accurate prognostication is crucial for timely clinical intervention and management.
- Developing a reliable grading scale can aid in identifying high-risk individuals.
Purpose of the Study:
- To develop and validate a Cerebral Venous Thrombosis Grading Scale (CVT-GS).
- To aid in short-term clinical decision-making for CVT patients.
- To predict 30-day mortality and functional outcomes (modified Rankin Scale > 2).
Main Methods:
- Retrospective analysis of 467 consecutive CVT patients hospitalized between 1981 and 2015.
- Bivariate analyses identified factors associated with 30-day mortality.
- Cox proportional-hazards model integrated factors into the CVT-GS, which was validated for predicting outcomes.
Main Results:
- The 30-day case fatality rate was 9.0%.
- The CVT-GS incorporates parenchymal lesion size, Babinski signs, sex, hemorrhage, and consciousness level.
- Mild, moderate, and severe CVT-GS categories showed distinct 30-day fatality rates (0.4%, 9.9%, and 61.4%, respectively).
- CVT-GS achieved 91.6% accuracy for predicting 30-day mortality and 85.3% for predicting mRS > 2.
Conclusions:
- The CVT-GS is a practical clinical tool for predicting short-term outcomes in CVT patients.
- This grading scale can assist in clinical decision-making and patient stratification for clinical trials.
- The CVT-GS offers valuable prognostic information for managing CVT.
Abstract:
Background: Most patients with cerebral venous thrombosis (CVT) have independent survival in the short term. However, identification of high-risk individuals with an unfavorable outcome is a challenging task. We aimed to develop a CVT grading scale (CVT-GS) to aid in the short-term clinical decision-making. Methods: We included 467 consecutive patients with CVT who were hospitalized from 1981 to 2015 in two third-level referral hospitals. Factors associated with 30-day mortality were selected with bivariate analyses to integrate a Cox proportional-hazards model to determine components of the final scoring. After the scale was configured, the prognostic performance was tested for prediction of short-term death or moderately impaired to death [modified Rankin scale (mRS) > 2]. CVT-GS was categorized as mild, moderate or severe for the prediction of 30-day fatality rate and a probability of mRS > 2. Results: The 30-day case fatality rate was 9.0%. The CVT-GS (0-13 points; more points predicting poorer outcomes) was composed of parenchymal lesion size > 6 cm (3 points), bilateral Babinski signs (3 points), male sex (2 points), parenchymal hemorrhage (2 points), and level of consciousness (coma: 3 points, stupor: 2, somnolence: 1, and alert: 0). CVT was categorized as mild (0-2 points, 0.4% fatality rate), moderate (3-7 points, 9.9% fatality rate), or severe (8-13 points, 61.4% fatality rate). The CVT-GS had an accuracy of 91.6% for the prediction of 30-day mortality and 85.3% for mRS > 2. Conclusions: CVT-GS is a practical clinical tool for prediction of outcome after CVT. This score may aid in clinical decision-making and could serve to stratify patients enrolled in clinical trials.
Related Concept Videos
Venous Thrombosis I: Introduction
Predicting Reaction Outcomes
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Introduction to z Scores
z scores...

